NASDAQ:NH - NantHealth Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.48 +0.13 (+3.88 %)
(As of 05/27/2018 03:33 AM ET)
Previous Close$3.48
Today's Range$3.30 - $3.4920
52-Week Range$2.60 - $5.26
Volume110,254 shs
Average Volume66,744 shs
Market Capitalization$363.78 million
P/E Ratio-3.11
Dividend YieldN/A
Beta0.19

About NantHealth (NASDAQ:NH)

NantHealth logoNantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NH
CUSIPN/A
Phone310-883-1300

Debt

Debt-to-Equity Ratio1.15
Current Ratio1.90
Quick Ratio1.88

Price-To-Earnings

Trailing P/E Ratio-3.11
Forward P/E Ratio-5.70
P/E GrowthN/A

Sales & Book Value

Annual Sales$86.68 million
Price / Sales4.36
Cash FlowN/A
Price / CashN/A
Book Value$1.58 per share
Price / Book2.20

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-175,210,000.00
Net Margins-168.84%
Return on Equity-63.06%
Return on Assets-28.77%

Miscellaneous

Employees494
Outstanding Shares108,590,000

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth (NASDAQ:NH) released its earnings results on Wednesday, March, 14th. The company reported ($0.21) EPS for the quarter. The business had revenue of $22.30 million for the quarter, compared to analysts' expectations of $23.50 million. NantHealth had a negative net margin of 168.84% and a negative return on equity of 63.06%. View NantHealth's Earnings History.

What price target have analysts set for NH?

3 brokerages have issued twelve-month target prices for NantHealth's stock. Their forecasts range from $4.50 to $5.00. On average, they expect NantHealth's share price to reach $4.8333 in the next year. View Analyst Ratings for NantHealth.

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Dr. Patrick Soon-Shiong, Founder, Chairman & CEO (Age 65)
  • Mr. Paul A. Holt, Chief Financial Officer (Age 52)
  • Mr. Ronald Allen Louks, Chief Operating Officer (Age 53)
  • Mr. Brandon Villery, VP & Gen. Counsel
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Has NantHealth been receiving favorable news coverage?

News coverage about NH stock has trended somewhat positive on Sunday, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. NantHealth earned a coverage optimism score of 0.24 on Accern's scale. They also gave media stories about the company an impact score of 47.10 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are NantHealth's major shareholders?

NantHealth's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.97%) and Millennium Management LLC (0.07%). Company insiders that own NantHealth stock include Healthcare Solution Allscripts, Patrick Soon-Shiong and Ronald Allen Louks. View Institutional Ownership Trends for NantHealth.

Which major investors are selling NantHealth stock?

NH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and Millennium Management LLC. View Insider Buying and Selling for NantHealth.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $3.48.

How big of a company is NantHealth?

NantHealth has a market capitalization of $363.78 million and generates $86.68 million in revenue each year. The company earns $-175,210,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. NantHealth employs 494 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  151 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  283
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NantHealth (NASDAQ:NH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for NantHealth in the last 12 months. Their average twelve-month price target is $4.8333, suggesting that the stock has a possible upside of 38.89%. The high price target for NH is $5.00 and the low price target for NH is $4.50. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.8333$4.8333$9.00$9.00
Price Target Upside: 38.89% upside59.52% upside152.81% upside152.81% upside

NantHealth (NASDAQ:NH) Consensus Price Target History

Price Target History for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ:NH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/21/2018Jefferies GroupSet Price TargetBuy$5.00HighView Rating Details
3/20/2018CowenReiterated RatingBuy$4.50LowView Rating Details
11/17/2017Canaccord GenuityLower Price TargetBuy ➝ Buy$6.00 ➝ $5.00N/AView Rating Details
4/3/2017Cantor FitzgeraldLower Price TargetOverweight$15.00 ➝ $13.00HighView Rating Details
4/1/2017FBR & CoSet Price TargetBuy$13.00HighView Rating Details
6/27/2016First AnalysisInitiated CoverageOverweight$18.00N/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

NantHealth (NASDAQ:NH) Earnings History and Estimates Chart

Earnings by Quarter for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ:NH) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.61 EPS
Next Year EPS Consensus Estimate: $-0.45 EPS

NantHealth (NASDAQ NH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018Q1 2018($0.12)($0.12)$23.30 million$22.26 millionViewN/AView Earnings Details
3/14/2018Q4 2017($0.21)$23.50 million$22.30 millionViewN/AView Earnings Details
11/9/2017Q3 2017($0.14)($0.13)$29.42 million$21.76 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.26)($0.58)$31.28 million$26.23 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.20)($0.24)$29.06 million$22.51 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.19)($0.18)$30.02 million$24.10 millionViewN/AView Earnings Details
11/7/2016Q3 2016($0.27)($0.22)$26.05 million$25.36 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.65)($0.59)$23.45 million$31.49 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

NantHealth (NASDAQ:NH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

NantHealth (NASDAQ NH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 58.00%
Institutional Ownership Percentage: 5.59%
Insider Trading History for NantHealth (NASDAQ:NH)
Institutional Ownership by Quarter for NantHealth (NASDAQ:NH)

NantHealth (NASDAQ NH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/6/2018Ronald Allen LouksCOOSell7,005$3.41$23,887.05177,391View SEC Filing  
4/6/2018Ronald Allen LouksCOOSell7,005$3.04$21,295.2089,690View SEC Filing  
3/6/2018Ronald Allen LouksCOOSell7,095$3.56$25,258.2089,690View SEC Filing  
2/6/2018Ronald Allen LouksCOOSell6,475$3.02$19,554.5089,690View SEC Filing  
1/8/2018Ronald Allen LouksCOOSell6,175$3.52$21,736.0089,690View SEC Filing  
12/6/2017Ronald Allen LouksCOOSell5,245$3.03$15,892.3589,690View SEC Filing  
11/6/2017Ronald Allen LouksCOOSell6,705$3.39$22,729.9510,000View SEC Filing  
10/6/2017Ronald Allen LouksCOOSell26,820$4.28$114,789.60View SEC Filing  
6/7/2016Healthcare Solution AllscriptsMajor ShareholderBuy714,286$14.00$10,000,004.0015,000,000View SEC Filing  
6/7/2016Patrick Soon-ShiongCEOBuy357,143$14.00$5,000,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NantHealth (NASDAQ NH) News Headlines

Source:
DateHeadline
Analyzing NantHealth (NH) & Sohu.com (SOHU)Analyzing NantHealth (NH) & Sohu.com (SOHU)
www.americanbankingnews.com - May 25 at 5:23 PM
PacketFabric Announces Scalable and Secure Cloud Connectivity to the Global Leader in CRMPacketFabric Announces Scalable and Secure Cloud Connectivity to the Global Leader in CRM
globenewswire.com - May 22 at 9:30 AM
NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications of Skin Cancer ...NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications of Skin Cancer ...
www.businesswire.com - May 21 at 4:15 PM
Lab7 Systems Appoints New CEO and Changes Name to L7 InformaticsLab7 Systems Appoints New CEO and Changes Name to L7 Informatics
www.globenewswire.com - May 15 at 10:22 AM
NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and ...NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and ...
www.businesswire.com - May 14 at 4:15 PM
NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and Future Insights to Patient Care at the Largest E-Health Event in ScandinaviaNantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and Future Insights to Patient Care at the Largest E-Health Event in Scandinavia
finance.yahoo.com - May 14 at 4:15 PM
NantHealth (NH) Posts Quarterly  Earnings Results, Hits ExpectationsNantHealth (NH) Posts Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - May 10 at 11:33 PM
CORRECTING and REPLACING NantHealth Reports 2018 First-Quarter Financial ResultsCORRECTING and REPLACING NantHealth Reports 2018 First-Quarter Financial Results
www.businesswire.com - May 10 at 4:21 PM
NantHealths (NH) Management on Q1 2018 Results - Earnings Call TranscriptNantHealth's (NH) Management on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 9:58 AM
Edited Transcript of NH earnings conference call or presentation 9-May-18 8:30pm GMTEdited Transcript of NH earnings conference call or presentation 9-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 9:58 AM
NantHealth (NH) Lifted to Buy at BidaskClubNantHealth (NH) Lifted to Buy at BidaskClub
www.americanbankingnews.com - May 10 at 12:36 AM
NantHealth Reports 2018 First-Quarter Financial ResultsNantHealth Reports 2018 First-Quarter Financial Results
finance.yahoo.com - May 9 at 4:18 PM
Ronald Allen Louks Sells 7,005 Shares of NantHealth (NH) StockRonald Allen Louks Sells 7,005 Shares of NantHealth (NH) Stock
www.americanbankingnews.com - May 8 at 4:32 PM
NantHealth (NH) & NantOmics Announce Study Results Highlighting High Error Rates in Tumor-Only Sequencing for ...NantHealth (NH) & NantOmics Announce Study Results Highlighting High Error Rates in Tumor-Only Sequencing for ...
www.streetinsider.com - May 7 at 9:32 AM
NantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer TreatmentNantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment
finance.yahoo.com - May 7 at 9:32 AM
Form 4 NantHealth, Inc. For: May 01 Filed by: HOLT PAULForm 4 NantHealth, Inc. For: May 01 Filed by: HOLT PAUL
www.streetinsider.com - May 4 at 9:37 AM
NantHealth to Report 2018 First-Quarter Financial Results and Host Conference Call on Wednesday, May 9NantHealth to Report 2018 First-Quarter Financial Results and Host Conference Call on Wednesday, May 9
finance.yahoo.com - May 4 at 9:37 AM
NantHealth (NH) Upgraded at ValuEngineNantHealth (NH) Upgraded at ValuEngine
www.americanbankingnews.com - May 2 at 11:06 PM
NantHealth Inc (NH) Given Consensus Recommendation of "Buy" by BrokeragesNantHealth Inc (NH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 2 at 3:34 AM
NantHealth (NH) Set to Announce Earnings on TuesdayNantHealth (NH) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - May 1 at 7:51 AM
NantHealth Inc (NH) COO Sells $21,295.20 in StockNantHealth Inc (NH) COO Sells $21,295.20 in Stock
www.americanbankingnews.com - April 10 at 10:16 PM
NantHealth (NH) Lowered to Sell at BidaskClubNantHealth (NH) Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 6 at 7:00 PM
NantHealth (NH) Downgraded by Zacks Investment ResearchNantHealth (NH) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 5 at 5:46 PM
NantHealth Has Turned A CornerNantHealth Has Turned A Corner
seekingalpha.com - April 2 at 4:17 PM
NantHealth (NH) Downgraded by BidaskClubNantHealth (NH) Downgraded by BidaskClub
www.americanbankingnews.com - April 1 at 5:55 PM
Edited Transcript of NH earnings conference call or presentation 14-Mar-18 8:30pm GMTEdited Transcript of NH earnings conference call or presentation 14-Mar-18 8:30pm GMT
finance.yahoo.com - April 1 at 9:55 AM
NantHealth (NH) Raised to Sell at BidaskClubNantHealth (NH) Raised to Sell at BidaskClub
www.americanbankingnews.com - March 30 at 2:19 PM
NantHealth (NH) Lowered to "Hold" at Zacks Investment ResearchNantHealth (NH) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:17 AM
NantHealth (NH) Lifted to Buy at Zacks Investment ResearchNantHealth (NH) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - March 29 at 12:34 AM
NantHealth (NH) Upgraded to "Hold" by BidaskClubNantHealth (NH) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - March 28 at 12:00 AM
NantHealth Inc (NH) Given Consensus Recommendation of "Buy" by AnalystsNantHealth Inc (NH) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 27 at 1:38 AM
BidaskClub Upgrades NantHealth (NH) to HoldBidaskClub Upgrades NantHealth (NH) to Hold
www.americanbankingnews.com - March 24 at 12:28 PM
NantHealths (NH) CEO Dr. Patrick Soon-Shiong on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaNantHealth's (NH) CEO Dr. Patrick Soon-Shiong on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 22 at 4:10 PM
Jefferies Group Analysts Give NantHealth (NH) a $5.00 Price TargetJefferies Group Analysts Give NantHealth (NH) a $5.00 Price Target
www.americanbankingnews.com - March 21 at 7:48 PM
Cowen Reaffirms "Buy" Rating for NantHealth (NH)Cowen Reaffirms "Buy" Rating for NantHealth (NH)
www.americanbankingnews.com - March 20 at 1:17 PM
BRIEF-Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing‍BRIEF-Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing‍
www.reuters.com - March 17 at 9:57 AM
NantHealth Reports 2017 Fourth-Quarter and Full-Year Financial ResultsNantHealth Reports 2017 Fourth-Quarter and Full-Year Financial Results
finance.yahoo.com - March 14 at 5:24 PM
NantHealth Q4 Earnings PreviewNantHealth Q4 Earnings Preview
finance.yahoo.com - March 14 at 5:24 PM
Rockville biotech founded by L.A. billionaire to lay off 52Rockville biotech founded by L.A. billionaire to lay off 52
finance.yahoo.com - March 13 at 6:05 PM
NantHealth (NH) Set to Announce Earnings on WednesdayNantHealth (NH) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - March 10 at 8:04 PM
NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday ... - Business Wire (press release)NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday ... - Business Wire (press release)
www.businesswire.com - March 9 at 10:35 AM
NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14
finance.yahoo.com - March 9 at 10:35 AM
Ronald Allen Louks Sells 7,095 Shares of NantHealth Inc (NH) StockRonald Allen Louks Sells 7,095 Shares of NantHealth Inc (NH) Stock
www.americanbankingnews.com - March 8 at 9:50 PM
NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
finance.yahoo.com - March 5 at 4:47 PM
Reviewing NantHealth (NH) & Omnicell (OMCL)Reviewing NantHealth (NH) & Omnicell (OMCL)
www.americanbankingnews.com - February 27 at 3:06 AM
[$$] Former Officials Raise Questions About New LA Times Owner’s Business[$$] Former Officials Raise Questions About New LA Times Owner’s Business
finance.yahoo.com - February 12 at 8:56 AM
[$$] Former Officials Raise Questions About New LA Times Owners Business[$$] Former Officials Raise Questions About New LA Times Owner's Business
finance.yahoo.com - February 10 at 8:54 AM
Baltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaireBaltimore Sun parent Tronc to sell Los Angeles Times to L.A. billionaire
www.bizjournals.com - February 8 at 9:05 AM
Insider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of StockInsider Selling: NantHealth Inc (NH) COO Sells 6,475 Shares of Stock
www.americanbankingnews.com - February 8 at 4:20 AM
Tronc to sell Los Angeles Times: sourceTronc to sell Los Angeles Times: source
www.reuters.com - February 7 at 9:02 AM

SEC Filings

NantHealth (NASDAQ:NH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NantHealth (NASDAQ:NH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NantHealth (NASDAQ NH) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.